307 related articles for article (PubMed ID: 31520196)
21. Encapsulation of podophyllotoxin and etoposide in biodegradable poly-D,L-lactide nanoparticles improved their anticancer activity.
Yadav R; Kumar D; Kumari A; Yadav SK
J Microencapsul; 2014; 31(3):211-9. PubMed ID: 24102094
[TBL] [Abstract][Full Text] [Related]
22. Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(D, L-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Eur J Pharm Biopharm; 2010 Jun; 75(2):96-106. PubMed ID: 20211727
[TBL] [Abstract][Full Text] [Related]
23. Targeted delivery and apoptosis induction of CDK-4/6 inhibitor loaded folic acid decorated lipid-polymer hybrid nanoparticles in breast cancer cells.
Rajana N; Sandeep Chary P; Bhavana V; Deshmukh R; Dukka K; Sharma A; Kumar Mehra N
Int J Pharm; 2024 Feb; 651():123787. PubMed ID: 38184023
[TBL] [Abstract][Full Text] [Related]
24. Biosurfactant stabilized anticancer biomolecule-loaded poly (D,L-lactide) nanoparticles.
Kumar V; Kumari A; Kumar D; Yadav SK
Colloids Surf B Biointerfaces; 2014 May; 117():505-11. PubMed ID: 24581629
[TBL] [Abstract][Full Text] [Related]
25. Folic acid-modified ginsenoside Rg5-loaded bovine serum albumin nanoparticles for targeted cancer therapy in vitro and in vivo.
Dong Y; Fu R; Yang J; Ma P; Liang L; Mi Y; Fan D
Int J Nanomedicine; 2019; 14():6971-6988. PubMed ID: 31507319
[TBL] [Abstract][Full Text] [Related]
26. Dodecanol-poly(D,L-lactic acid)-b-poly (ethylene glycol)-folate (Dol-PLA-PEG-FA) nanoparticles: evaluation of cell cytotoxicity and selecting capability in vitro.
Wang S; Luo Y; Zeng S; Luo C; Yang L; Liang Z; Wang Y
Colloids Surf B Biointerfaces; 2013 Feb; 102():130-5. PubMed ID: 23000678
[TBL] [Abstract][Full Text] [Related]
27. Hyaluronic acid shell and disulfide-crosslinked core micelles for in vivo targeted delivery of bortezomib for the treatment of multiple myeloma.
Gu Z; Wang X; Cheng R; Cheng L; Zhong Z
Acta Biomater; 2018 Oct; 80():288-295. PubMed ID: 30240956
[TBL] [Abstract][Full Text] [Related]
28. Bortezomib-loaded solid lipid nanoparticles: preparation, characterization, and intestinal permeability investigation.
Mahmoudian M; Valizadeh H; Zakeri-Milani P
Drug Dev Ind Pharm; 2018 Oct; 44(10):1598-1605. PubMed ID: 29874944
[TBL] [Abstract][Full Text] [Related]
29.
Rani S; Sahoo RK; Kumar V; Chaurasiya A; Kulkarni O; Mahale A; Katke S; Kuche K; Yadav V; Jain S; Nakhate KT; Ajazuddin ; Gupta U
Mol Pharm; 2023 Jan; 20(1):524-544. PubMed ID: 36306447
[TBL] [Abstract][Full Text] [Related]
30. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
[TBL] [Abstract][Full Text] [Related]
31. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of the intestinal absorption of bortezomib by self-nanoemulsifying drug delivery system.
Mahmoudian M; Valizadeh H; Löbenberg R; Zakeri-Milani P
Pharm Dev Technol; 2020 Mar; 25(3):351-358. PubMed ID: 31810410
[No Abstract] [Full Text] [Related]
33. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells.
Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R
Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951
[TBL] [Abstract][Full Text] [Related]
34. Co-delivery of docetaxel and bortezomib based on a targeting nanoplatform for enhancing cancer chemotherapy effects.
Nie J; Cheng W; Peng Y; Liu G; Chen Y; Wang X; Liang C; Tao W; Wei Y; Zeng X; Mei L
Drug Deliv; 2017 Nov; 24(1):1124-1138. PubMed ID: 28789585
[TBL] [Abstract][Full Text] [Related]
35. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
Feng SS; Mei L; Anitha P; Gan CW; Zhou W
Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
[TBL] [Abstract][Full Text] [Related]
36. Development of nanoformulation of picroliv isolated from Picrorrhiza kurroa.
Guliani A; Kumari A; Kumar D; Yadav SK
IET Nanobiotechnol; 2016 Jun; 10(3):114-9. PubMed ID: 27256889
[TBL] [Abstract][Full Text] [Related]
37. Utilization of Lipid-based Nanoparticles to Improve the Therapeutic Benefits of Bortezomib.
Korani M; Korani S; Zendehdel E; Jaafari MR; Sathyapalan T; Sahebkar A
Anticancer Agents Med Chem; 2020; 20(6):643-650. PubMed ID: 31985384
[TBL] [Abstract][Full Text] [Related]
38. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
[TBL] [Abstract][Full Text] [Related]
39. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
40. Arg-Gly-Asp (RGD) peptide conjugated poly(lactic acid)-poly(ethylene oxide) micelle for targeted drug delivery.
Hu Z; Luo F; Pan Y; Hou C; Ren L; Chen J; Wang J; Zhang Y
J Biomed Mater Res A; 2008 Jun; 85(3):797-807. PubMed ID: 17896765
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
